Preclinical studies showed promising NK cell-mediated antitumor activity with increased levels of cytokine secretion, cytolysis of tumor cells via increased levels of IFN-γ, and antibody-dependent tumor cytotoxicity mediated by increased levels of IFN-α [159]. The gene discussed is IFNA1; the disease is neoplasm.